Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028
Kyntra Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $6.90
-5.3% since the alert
$7.22 → $6.84
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS